Clinical trial
Evaluation of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
NCT03539549 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
- Lead sponsor
- Allergan
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 25, 2018
- Completion date
- February 27, 2019
- Enrollment
- 124 (actual)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.